Pfizer and Biontech announced completing Phase 3 for their Covid vaccine on Nov 10, but their stocks showed little progress in November:
2% less than S&P 500 for PFE and 15 % more for BNTX, which, as a small company, should benefit more than that just because of lifting their brand in the spotline.



Leave a comment

  1. Unknown's avatar
  2. Unknown's avatar
  3. Deminvest's avatar
  4. Deminvest's avatar
  5. Deminvest's avatar